Related Experiment Video
Updated: Jan 13, 2026
Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
Factors affecting survival in patients with colorectal cancer: an umbrella review
Lulin Yu1, Jing Yuan1, Simin Lou1
1The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine), Hangzhou, Zhejiang, 310022, China.
Background:
This study aimed to evaluate the strength and validity of the evidence for reported associations between multiple factors and colorectal cancer (CRC) survival.
Methods:
We searched PubMed, Embase, Cochrane Database of Systematic Reviews from inception to 20 June 2024 for systematic reviews and meta-analyses of observational studies on factors and CRC prognosis. The quality of the methodology was evaluated using A Measurement Tool to Assess systematic Reviews 2 (AMSTAR-2).
Results:
90 meta-analyses investigated 191 associations (123 main evidence and 68 supplementary evidence) with CRC overall survival (OS). Factors were categorized into: demographic characteristic, perioperative condition, pathology of neoplasia, clinical laboratory indicators, comorbidities, behavior patterns and others. Totally, 6 associations were recommended as strong evidence (class I). While the presence of chemotherapy-induced neutropenia (CIN) (hazard ratio [HR] = 0.40, 95% confidence interval [CI] 0.32-0.51) denoted a better OS outcome, the existence of log odds of positive lymph nodes (LODDS) (HR = 3.49, 95% CI 2.88-4.23), liver cirrhosis (HR = 3.10, 95% CI 2.68-3.59) and the increment of metastatic lymph node ratio (mLNR) (HR = 1.62, 95% CI 1.39-1.88), pretreatment neutrophils-lymphocytes ratio (NLR) (HR = 2.17, 95% CI 1.83-2.58) and pretreatment lymph node ratio (LNR) (HR = 3.13, 95% CI 2.36-4.15) were considered as poor predictors of OS. Notably, 2 strong evidence was also found in supplementary evidence including extranodal tumor deposits (ENTDs) (HR = 1.72, 95% CI 1.46-2.04) and absolute monocyte count (AMC) (HR = 1.83, 95% CI 1.47-2.29).
Conclusion:
Beyond high-risk pathological signs of lymph node status and ENTDs, optimizable and cost-effective laboratory indicators, such as CIN, NLR, LNR and AMC, may effectively predict the prognosis of CRC. Furthermore, our study provides valuable insights for stratified CRC patient management, reinforcing the development of evidence-based prognostic survival strategies and recommendations.
Trial Registration:
This protocol was registered with PROSPERO under CRD42024560003.
More Related Videos
06:24Author Spotlight: Liujunzi Decoction as a Traditional Chinese Treatment for Coloproctitis Cancer
Published on: October 13, 2023
07:13Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model
Published on: April 18, 2025
Related Concept Videos
01:21Cancer Survival Analysis
01:20Comparing the Survival Analysis of Two or More Groups
02:49Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
01:15Assumptions of Survival Analysis
01:25Factors Influencing Drug Absorption: Disease States and Pharmacology
Substances such as alcohol and specific drugs, including antineoplastics, can also negatively impact drug absorption. For instance,...
01:18Factors Affecting Illness
For instance, risk factors are connected to illness,...